首页>
外国专利>
GCNT2/I-BRANCHING AS A BIOMARKER OF MELANOMA PROGRESSION
GCNT2/I-BRANCHING AS A BIOMARKER OF MELANOMA PROGRESSION
展开▼
机译:GCNT2 / I-分支作为黑素瘤进展的生物标志物
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention provides methods and composition for diagnosis, prognosis, prevention and/or treatment of cancers such as melanomas. The subject invention provides biomarkers and methods for assessing the severity of a cancer/tumor and for monitoring the progressing of a cancer/tumor. The biomarkers include glycosylation-rerated genes and molecules affected by the glycosylation-rerated genes. The compositions according to the subject invention regulate malignancy-associated pathways and alter melanoma signaling, growth, and survival.
展开▼